Metabolic and vascular actions of endothelin-1 are inhibited by insulin-mediated vasodilation in perfused rat hindlimb muscle

British Journal of Pharmacology

Volumn 145, Issue 7, 2005, Pages 992-1000

  Kolka, Cathryn M ^a   Rattigan, Stephen ^a   Richards, Stephen ^a   Clark, Michael G ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Blood flow; Endothelin; Insulin mediated glucose uptake; Metabolism; Vasoconstriction

Indexed keywords

ENDOTHELIN 1; GLUCOSE; INSULIN; LACTIC ACID; NITROPRUSSIDE SODIUM;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; DRUG POTENTIATION; GLUCOSE TRANSPORT; HINDLIMB; LOW DRUG DOSE; MALE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; VASODILATATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENDOTHELIN-1; GLUCOSE; HINDLIMB; INSULIN; LACTIC ACID; MALE; MUSCLE, SKELETAL; NITROPRUSSIDE; OXYGEN CONSUMPTION; PERFUSION; RATS; RATS, WISTAR; VASOCONSTRICTION; VASODILATION;

EID: 23744456126     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706263     Document Type: Article

References (25)

1. CARDILLO, C., CAMPIA, U., BRYANT, M.B. & PANZA, J.A. (2002). Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation, 106, 1783-1787.
2. CARDILLO, C., NAMBI, S.S., KILCOYNE, C.M., CHOUCAIR, W.K., KATZ, A., QUON, M.J. & PANZA, J.A. (1999). Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation, 100, 820-825.
3. CLARK, M.G., COLQUHOUN, E.Q., RATTIGAN, S., DORA, K.A., ELDERSHAW, T.P., HALL, J.L. & YE, J. (1995). Vascular and endocrine control of muscle metabolism. Am. J. Physiol., 268, E797-E812.
4. COLQUHOUN, E.Q., HETTIARACHCHI, M., YE, J.M., RICHTER, E.A., HNIAT, A.J., RATTIGAN, S. & CLARK, M.G. (1988). Vasopressin and angiotensin II stimulate oxygen uptake in the perfused rat hindlimb. Life Sci., 43, 1747-1754.
5. DORLEANS-JUSTE, P., CLAING, A., WARNER, T.D., YANO, M. & TELEMAQUE, S. (1993). Characterization of receptors for endothelins in the perfused arterial and venous mesenteric vasculatures of the rat. Br. J. Pharmacol., 110, 687-692.
6. DE NUCCI, G., THOMAS, R., D'ORLEANS-JUSTE, P., ANTUNES, E., WALDER, C., WARNER, T.D. & VANE, J.R. (1988). Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. U.S.A., 85, 9797-9800.
7. DORA, K.A., RATTIGAN, S., COLQUHOUN, E.Q. & CLARK, M.G. (1994). Aerobic muscle contraction impaired by serotonin-mediated vasoconstriction. J. Appl. Physiol., 77, 277-284.
8. DORA, K.A., RICHARDS, S.M., RATTIGAN, S., COLQUHOUN, E.Q. & CLARK, M.G. (1992). Serotonin and norepinephrine vasoconstriction in rat hindlimb have different oxygen requirements. Am. J. Physiol., 262, H698-H703.
9. ERINGA, E.G., STEHOUWER, C.D., MERLIJN, T., WESTERHOF, N. & SIPKEMA, P. (2002). Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or PI3-kinase in skeletal muscle arterioles. Cardiovasc. Res., 56, 464-471.
10. FERRI, C., CARLOMAGNO, A., COASSIN, S., BALDONCINI, R., FALDETTA, M.R.C., LAURENTI, O., PROPERZI, G., SANTUCCI, A. & DE MATTIA, G. (1995). Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men. Diabetes Care, 18, 226-233.
11. IDRIS, I., PATIAG, D., GRAY, S. & DONNELLY, R. (2001). Tissue-and time-dependent effects of endothelin-1 on insulin-stimulated glucose uptake. Biochem. Pharmacol., 62, 1705-1708.
12. JUST, A., OLSON, A.J. & ARENDSHORST, W.J. (2004). Dual constrictor and dilator actions of ET(B) receptors in the rat renal microcirculation: interactions with ET(A) receptors. Am. J. Physiol. Renal Physiol., 286, F660-F668.
13. KEDZIERSKI, R.M. & YANAGISAWA, M. (2001). Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol., 41, 851-876.
14. A receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br. J. Pharmacol., 115, 191-197.
15. MATHER, K.J., MIRZAMOHAMMADI, B., LTEIF, A., STEINBERG, H.O. & BARON, A.D. (2002). Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes, 51, 3517-3523.
16. MCENIERY, C.M., WILKINSON, I.B., JENKINS, D.G. & WEBB, D.J. (2002). Endogenous endothelin-1 limits exercise-induced vasodilation in hypertensive humans. Hypertension, 40, 202-206.
17. NEWMAN, J.M., DORA, K.A., RATTIGAN, S., EDWARDS, S.J., COLQUHOUN, E.Q. & CLARK, M.G. (1996). Norepinephrine and serotonin vasoconstriction in rat hindlimb control different vascular flow routes. Am. J. Physiol., 270, E689-E699.
18. OTTOSSON-SEEBERGER, A., LUNDBERG, J.M., ALVESTRAND, A. & AHLBORG, G. (1997). Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans. Acta Physiol. Scand., 161, 211-220.
19. B receptors in regulation of cardiac contractile function in mice. Am. J. Physiol. Heart Circ. Physiol., 285, H112-H118.
20. PLUSCZYK, T., BERSAL, B., MENGER, M.D. & FEIFEL, G. (2001). Differential effects of ET-1, ET-2, and ET-3 on pancreatic microcirculation, tissue integrity, and inflammation. Dig. Dis. Sci., 46, 1343-1351.
21. RATTIGAN, S., DORA, K.A., COLQUHOUN, E.Q. & CLARK, M.G. (1993). Serotonin-mediated acute insulin resistance in the perfused rat hindlimb but not in incubated muscle: a role for the vascular system. Life Sci., 53, 1545-1555.
22. RICH, S. & MCLAUGHLIN, V.V. (2003). Endothelin receptor blockers in cardiovascular disease. Circulation, 108, 2184-2190.
23. RUDERMAN, N.B., HOUGHTON, C.R. & HEMS, R. (1971). Evaluation of the isolated perfused rat hindquarter for the study of muscle metabolism. Biochem. J., 124, 639-651.
24. VERMA, S., YAO, L., STEWART, D.J., DUMONT, A.S., ANDERSON, T.J. & MCNEILL, J.H. (2001). Endothelin antagonism uncovers Insulin-mediated vasorelaxation in vitro and in vivo. Hypertension, 37, 328-333.
25. WARNER, T.D., MITCHELL, J.A., DE NUCCI, G. & VANE, J.R. (1989). Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J. Cardiovasc. Pharmacol., 13, S85-S88.